AzTrials
AzTrials

Healthy Subjects or VolunteersNCT07073989

Investigating the Impact of Afferent Stimulation on Proprioceptive Function in Post-Stroke Rehabilitation

A study testing Afferent stimulation in people with Healthy Subjects or Volunteers and Chronic Stroke, run by Julio S. Lora Millán at 1 site in Spain.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The objective of this study is to assess the functionality of a sensory stimulation device that uses mechanical vibrations and low-intensity electrical currents to deliver proprioceptive feedback to stroke patients regarding their movements. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
Afferent stimulation
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteSpain
Study dates
17 Jun 2025to Sep 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • For healthy subjects:
  • No neurological or orthopedic conditions affecting upper limb movement.
  • No surgical interventions on the upper limbs within the past 6 months.
  • General physical condition adequate to perform the session.
  • Cognitive abilities sufficient to understand and carry out the experimental procedure.
  • For stroke survivors:
Show all 16Show fewer
  • Ischemic or hemorrhagic stroke resulting in motor impairments in the upper limb.
  • Chronic stroke condition.
  • Subjects with sufficient cognitive abilities to follow instructions and actively participate in the therapy.
  • Mini-Mental State Examination (MMSE) score > 24.
  • Subjects presenting hemiparesis and mild-to-moderate impairment in the upper limb (score on the Fugl-Meyer Motor Assessment for the upper limb, sections A-D, between 35 and 53 points). The maximum score on the FM scale is 66, with the following severity classifications:
  • 0-15: severe impairment
  • 16-34: moderate-to-severe impairment
  • 35-53: mild-to-moderate impairment
  • 54-66: mild impairment 6. Subjects presenting upper limb hypertonia with a score below 3 on the Modified Ashworth Scale.
  • 7. Subjects who have signed the informed consent document to voluntarily participate in the experiments.

Who cannot join

  • Acute musculoskeletal disorders.
  • Peripheral vascular diseases.
  • Acute cardiopulmonary conditions.
  • Acute neurological disorders.
  • Restricted mobility of upper limb joints due to any cause.
  • Pain as a cause of impaired upper limb mobility.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Julio S. Lora Millán, PhD in Automation and Robotics contact

914880000 ext. 4584

julio.lora@urjc.es

Spain1 site, 1 recruiting
  • Universidad Rey Juan Carlos

    Móstoles, Madrid, 28933

    Julio S Lora Millan, PhD in Automation and Robotics, 914884584 ext. 4584, julio.lora@urjc.es

    Recruiting

Other trials in Spain

About this study

The objective of this study is to assess the functionality of a sensory stimulation device that uses mechanical vibrations and low-intensity electrical currents to deliver proprioceptive feedback to stroke patients regarding their movements.

Being tested
Afferent stimulation
Keywords
Afferent stimulation, Proprioception

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Afferent stimulationDevice

    Stimulation applied through mechanical vibration or low-intensity electric currents

Study groups in NCT07073989
Study groupRoleWhat they receive
Healthy subjectsExperimentalIntervention applied to healthy subjects
Receives: Device: Afferent stimulation
Stroke patientsExperimentalStimulation applied to stroke patients
Receives: Device: Afferent stimulation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Motor illusion

    Motor illusion is evaluated by instructing the patient to replicate the movement they experienced in the contralateral limb. Inertial sensors will be placed in such limb to acquire the movement performed by the subject.

    Measured: Periprocedural

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Jul 2025
  2. Study start17 Jun 2025
  3. Primary completionSep 2025 (estimated)
  4. Study completionSep 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Single group
Masking
None (open label)
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07073989
Sponsor's protocol ID
NeuroBot_ESNA_v1
Status last verified
Jul 2025
First submitted
20 Jun 2025
Last updated
20 Jul 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Afferent stimulation in people with Healthy Subjects or Volunteers and Chronic Stroke, run by Julio S. Lora Millán at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 16 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 20 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Julio S. Lora Millán, PhD in Automation and Robotics (914880000 ext. 4584, julio.lora@urjc.es), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Motor illusion (time frame: Periprocedural). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Jul 2025; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in